J. Mitchell

Publications
Influence

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

J. Carmichael, W. Degraff, A. Gazdar, J. Minna, J. Mitchell
Biology, Medicine
Cancer research
15 February 1987

The clonogenic assay was more sensitive when continuous drug exposures were utilized, although this was primarily related to the increased drug exposure time, and therefore it offers a valid, simple method of assessing chemosensitivity in established cell lines.

View on PubMed

Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.

D. Wink, J. Mitchell
Biology, Chemistry
Free radical biology & medicine
1 September 1998

View on PubMed

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.

J. Carmichael, W. Degraff, A. Gazdar, J. Minna, J. Mitchell
Chemistry
Cancer research
15 February 1987

While optimal conditions for each cell line (cell number plated and doubling time) must be established, the 3-dimethylthiazol-2-yl)-2,5-diphenylformazan bromide assay could be automated and thus be of great value in screening large numbers of potential radiosensitizers or protectors.

View on PubMed

The multifaceted roles of nitric oxide in cancer.

D. Wink, Y. Vodovotz, J. Laval, F. Laval, M. Dewhirst, J. Mitchell
Chemistry, Biology
Carcinogenesis
1 May 1998

How the chemistry of NO may impact the initiation and progression stages of cancer is discussed.

View on PubMed

Viability measurements in mammalian cell systems.

J. Cook, J. Mitchell
Biology
Analytical biochemistry
15 May 1989

View on PubMed

Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide.

M. Krishna, D. Grahame, A. Samuni, J. Mitchell, A. Russo
Chemistry
Proceedings of the National Academy of Sciences…
15 June 1992

The results indicate that the dismutation of .O2- is catalyzed by the oxoammonium/nitroxide redox couple for carbocyclic nitroxide derivatives, and suggest the possibility that cellular bioreduction by a two-electron pathway may occur subsequent to oxidation of stable nitroxides.

View on Publisher

Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.

D. Wink, I. Hanbauer, M. Krishna, W. DeGraff, J. Gamson, J. Mitchell
Biology
Proceedings of the National Academy of Sciences…
1 November 1993

In the presence of NO released from (C2H5)2N[N(O)NO]-Na+ (DEA/NO), the cytotoxicity resulting from superoxide or hydrogen peroxide was markedly abrogated and this peroxide-mediated cytotoxic effect on mesencephalic cells was abolished.

View on PubMed

Nitric oxide (NO) protects against cellular damage by reactive oxygen species.

D. Wink, J. Cook, R. Pacelli, J. Liebmann, M. Krishna, J. Mitchell
Biology
Toxicology letters
1 December 1995

View on PubMed

Tempol, a stable free radical, is a novel murine radiation protector.

S. Hahn, Z. Tochner, J. Mitchell
Biology, Chemistry
Cancer research
1 April 1992

Tempol represents a new class of in vivo, non-sulfur-containing radiation protectors and has the potential for hypoxic radiosensitization and aerobic cell radioprotection, and Temporal or other analogues may have potential therapeutic application.

View on PubMed

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines.

J. Liebmann, J. Cook, C. Lipschultz, D. Teague, J. Fisher, J. Mitchell
Biology, Medicine
British Journal of Cancer
1 December 1993

It appears that modest concentrations (i.e., 50 nM) should be as effective as higher concentrations of paclitaxel, while Cremophor EL is a biologically active diluent and, at high concentrations, can antagonise pac litaxel cytotoxicity.

View on Nature

Recommended Authors